JENNIFER WEED: Open Payments
NPI 1285111922 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,593 in 105 payments from 21 companies in 2025. Trend: 2023 $2,413 · 2024 $2,711 · 2025 $2,593
Food & beverage: $2,593
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 14 | $294 |
| Collegium Pharmaceutical, Inc. | 17 | $266 |
| Teva Pharmaceuticals USA, Inc. | 6 | $197 |
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $184 |
| PFIZER INC. | 8 | $173 |
| Valinor Pharma, LLC | 10 | $167 |
| ABBVIE INC. | 9 | $146 |
| Spinal Simplicity, LLC | 2 | $143 |
| Saluda Medical Americas, Inc. | 4 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
Products named: XTAMPZA, AUSTEDO XR, JOURNAVX, MOVANTIK, NURTEC ODT, HA MINUTEMAN G3-R, WaveWriter Alpha Prime 16, Evoke.
Industry payments across PA — which companies pay providers there.
